title: Do we need another heart failure biomarker: focus on soluble suppression of tumorigenicity 2 (sST2).
authors.affiliation: Division of Cardiology, San Diego Veterans Affairs Medical Center and University of California, Vamc 3350 La Jolla Village Drive, San Diego CA 92161, USA.
authors.forename: Alan S
authors.initials: AS
authors.lastname: Maisel
authors.affiliation: Department of Medical-Surgery Sciences and Translational Medicine, Emergency Medicine Saint' Andrea Hospital, School of Medicine and Psychology, "Sapienza" University, Rome, Italy.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Di Somma
mesh_terms: D000553:Ambulatory Care; D015415:Biomarkers / Q000378:metabolism; D002908:Chronic Disease; D005544:Forecasting; D006442:Glycated Hemoglobin / Q000378:metabolism; D006333:Heart Failure / Q000097:blood / Q000175:diagnosis*; D006760:Hospitalization; D006801:Humans; D000072179:Interleukin-1 Receptor-Like 1 Protein / Q000378:metabolism*; D020097:Natriuretic Peptide, Brain / Q000378:metabolism; D018570:Risk Assessment; D016019:Survival Analysis
chemical_list: D015415:Biomarkers; D006442:Glycated Hemoglobin; D000072179:Interleukin-1 Receptor-Like 1 Protein; D020097:Natriuretic Peptide, Brain; C079241:IL1RL1 protein, human